aluminum chloride has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azevedo, RB; Cunha-Filho, M; Gelfuso, GM; Gratieri, T; Jaculi, AE; Joanitti, GA; Ramos, KLV; Reis, TA; Souza, PEN; Veiga-Souza, FH | 1 |
| Goto, PL; Siqueira-Moura, MP; Tedesco, AC | 1 |
2 other study(ies) available for aluminum chloride and B16 Melanoma
| Article | Year |
|---|---|
Combination of cyclodextrin complexation and iontophoresis as a promising strategy for the cutaneous delivery of aluminum-chloride phthalocyanine in photodynamic therapy.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Cutaneous; Aluminum Chloride; Animals; Cell Line, Tumor; Cell Survival; Indoles; Iontophoresis; Melanoma, Experimental; Mice; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Skin; Skin Absorption; Skin Neoplasms; Swine | 2019 |
Application of aluminum chloride phthalocyanine-loaded solid lipid nanoparticles for photodynamic inactivation of melanoma cells.
Topics: Aluminum Chloride; Animals; Cell Line, Tumor; Cell Survival; Indoles; Lipids; Melanoma, Experimental; Mice; Nanoparticles; NIH 3T3 Cells; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2017 |